Ferrero S, Evangelisti G, Barra F. Current and emerging treatment options for endometriosis. Expert Opin Pharmacother 2018;19:1109-1125. https://www.tandfonline.com/doi/abs/10.1080/14656566.2018.1494154?journalCode=ieop20
Current and Emerging Therapeutics for the Management of Endometriosis.
Ferrero S, Barra F, Leone Roberti Maggiore U. Current and Emerging Therapeutics for the Management of Endometriosis. Drugs 2018;78:995-1012. https://link.springer.com/article/10.1007%2Fs40265-018-0928-0
Prevention of adverse pulmonary, neurological, and ocular perinatal outcomes by supplementing omega-3 fatty acids during pregnancy
Ferro Desideri L, Barra F, Ferrero S. Prevention of adverse pulmonary, neurological, and ocular perinatal outcomes by supplementing omega-3 fatty acids during pregnancy. Am J Obstet Gynecol 2018;219:120-121. https://www.ajog.org/article/S0002-9378(18)30233-3/fulltext
Role of bevacizumab in uterine leiomyosarcoma. Crit Rev Oncol Hematol
Bogani G, Ditto A, Martinelli F, Signorelli M, Chiappa V, Fonatella C, Sanfilippo R, Leone Roberti Maggiore U, Ferrero S, Lorusso D, Raspagliesi F. Role of bevacizumab in uterine leiomyosarcoma. Crit Rev Oncol Hematol 2018;126:45-51. https://www.sciencedirect.com/science/article/abs/pii/S1040842817302226?via%3Dihub
Potential impact of introducing a nonavalent HPV vaccination. Int J Gynaecol Obstet
Bogani G, Taverna F, Lombardo C, Signorelli M, Chiappa V, Casarin J, Scaffa C, Leone Roberti Maggiore U, Recalcati D, Ditto A, Martinelli F, Borghi C, Perotto S, Ferrero S, Lorusso D, Raspagliesi F. Potential impact of introducing a nonavalent HPV vaccination. Int J Gynaecol Obstet 2018;142:338-342. https://obgyn.onlinelibrary.wiley.com/doi/abs/10.1002/ijgo.12546